Two new subtypes of MS found in ‘exciting’ breakthrough

Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...
The American Journal of Managed Care

Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression

Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, differentiate relapsing forms (relapsing-remitting and primary progressive) from ...
MedPage Today

For Your Patients: What Are the Different Types of MS?

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple ...
MedPage Today

For Your Patients: Understanding Progressive MS and Relapsing MS

Up to 85% of the people who receive a diagnosis of the neurodegenerative disorder multiple sclerosis (MS) have the relapsing-remitting (RR) disease course. This means that people have relapses -- also ...
WRAL

Stem cell therapy for relapsing MS proves effective and safe, study finds

An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system, new research ...
WebMD

Managing Multiple Sclerosis With Kesimpta: What You Need to Know

Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS ...
Healthline

Secondary Progressive Multiple Sclerosis (SPMS) and Switching Treatments

Improvements in safety, efficacy, and specificity have raised questions around the benefits and risks of switching treatments for this type of MS, especially from fingolimod to siponimod. There are ...
The Times and Democrat

Most people with MS have relapsing-remitting type

Dear Doctors: My older brother is 33 years old and was recently diagnosed with multiple sclerosis. I don't want to bother him with a lot of questions, but I would like to learn more about it. Can you ...
Medscape

NICE Recommends Ublituximab for Relapsing MS in Adults

The National Institute for Health and Care Excellence (NICE) has recommended ublituximab (Briumvi) for treating people with relapsing remitting multiple sclerosis (MS). The drug should be available ...
Seeking Alpha

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
Crain's Cleveland Business

Cleveland Clinic researcher advises Sanofi on multiple sclerosis drug that slows disease’s progression

Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, providing hope for patients for whom there’s currently no treatment. Tolebrutinib ...